Concurrent diabetes and heart failure: interplay and novel therapeutic approaches

Qutuba G Karwi1, Kim L Ho1, Simran Pherwani1

  • 1Department of Pediatrics, Cardiovascular Research Centre, University of Alberta, 423 Heritage Medical Research Centre, Edmonton, Alberta T6G 2S2, Canada.

Insights

Diabetes significantly increases heart failure risk, leading to diabetic cardiomyopathy. Understanding its mechanisms beyond high blood sugar is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is a major risk factor for heart failure.
  • The combination of diabetes and heart failure leads to poorer cardiovascular outcomes.
  • Hyperglycemia management alone is insufficient to prevent diabetes-induced heart failure.

Purpose of the Study:

  • To summarize diabetic cardiomyopathy characteristics.
  • To elucidate the underlying mechanisms of diabetic cardiomyopathy.
  • To review therapeutic impacts on diabetes and heart failure.

Main Methods:

  • Literature review of diabetic cardiomyopathy.
  • Analysis of mechanisms including insulin resistance, fuel preference, oxidative stress, inflammation, cell death, and metabolic dysfunctions.
  • Examination of antihyperglycemic and heart failure therapies.

Main Results:

  • Diabetic cardiomyopathy involves complex cardiac alterations.
  • Mechanisms include insulin resistance, lipotoxicity, glucotoxicity, oxidative stress, inflammation, and altered fuel metabolism.
  • Therapeutic strategies for both conditions have overlapping effects.

Conclusions:

  • Diabetic cardiomyopathy arises from multiple factors beyond hyperglycemia.
  • Further research is needed to fully understand diabetes-induced heart failure.
  • Integrated therapeutic approaches are essential for managing co-existing diabetes and heart failure.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
90
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
73
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
222
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
682
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
135
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
168